|
AKAM missed numbers in Q2 and lowered Q3 guidance. The stock tanked 20% after Q2 earnings call (from $21 to $16). I bought in the $16s and now the stock is higher than before the Q2 call. Almost $23. TSRA is going to be similar. It lowered guidance for Q4. Stock tanked 20% from $26 to $22. Again I bought at $22.05. By Q4 earnings in January this stock will be above $26, because they will beat the reduced guidance.
Again just look at AKAM. Rating :
 (No ratings) |
120/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
1.44